Weight-loss drugs avoid Wada banned list for 2027
Summary
The World Anti-Doping Agency (Wada) decided that weight-loss drugs like Ozempic and Mounjaro will not be banned for athletes in 2027 but will stay on a watch list. Wada is studying if these drugs, which affect body weight and metabolism, give athletes an unfair advantage or health risks before deciding on any future ban.Key Facts
- Wada monitors weight-loss drugs known as GLP-1 receptor agonists, including Ozempic and Mounjaro.
- These drugs will not be banned in 2027 but remain under observation by Wada.
- To ban a substance, it must meet at least two of three rules: boost performance, harm health, or break the spirit of sport.
- Wada is conducting studies to understand the drugs' effects on fit athletes, not just obese patients.
- Side effects like nausea, tiredness, and muscle loss could make the drugs harmful for athletes.
- Sports that focus on weight categories, like boxing or horse racing, might be most tempted to misuse these drugs.
- Some athletes, like Serena Williams, have publicly admitted using these weight-loss medications.
- About 12% of sports doctors know of athletes using these drugs without a medical need.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
